PROMAR INTERNATIONAL, INC. – Trademark Portfolio
Entity Type: 03
PROMAR INTERNATIONAL, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include AGRALYTICA, PROMAR INTERNATIONAL, and AGRALYTICA CONSULTING. The owner is based in New York, NY.
1411 Broadway
New York, NY 10036
Showing of trademarks Trademarks
Trademark Classifications
PROMAR INTERNATIONAL, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PROMAR INTERNATIONAL, INC. have?
PROMAR INTERNATIONAL, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 2 cancelled.
What trademark classes does PROMAR INTERNATIONAL, INC. file in?
PROMAR INTERNATIONAL, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 25 (Clothing). Class 35 covers advertising; business management; business administration; office functions.
What are PROMAR INTERNATIONAL, INC.'s most well-known trademarks?
PROMAR INTERNATIONAL, INC.'s registered trademark portfolio includes well-known marks such as AGRALYTICA, PROMAR INTERNATIONAL, and AGRALYTICA CONSULTING. These are among 4 currently registered trademarks in the portfolio.
What is PROMAR INTERNATIONAL, INC.'s trademark registration success rate?
PROMAR INTERNATIONAL, INC. has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.